Академический Документы
Профессиональный Документы
Культура Документы
Antimicrobial Agent
Beta-lactams ampicillin amoxicillin/clavulanate ampicillin/sulbactam meropenem oxacillin (nafcillin) penicillin G piperacillin/tazobactam
% Susceptible
91 91 52 7 44 7 59 78
Antimicrobial
93
58
90 91 67 92 98
95
Cephalosporins cefazolin 52 44 92 98 cefoxitin 90 cefpodoxime ceftriaxone 96 98 96 cefepime cefuroxime cephalexin Ceftriaxone also predicts the sensitivity to cefotaxime. Aminoglycosides amikacin gentamicin tobramycin Quinolones levooxacin Miscellaneous clarithromycin clindamycin erythromycin nitrofurantoin* tetracycline* trimethoprim/ sulfamethoxazole Vancomycin 100 93 99 93 99 56 43 100 65 82 97
91
96 78 100 98
98
98 100 82 91 64
95 80 90 66
73
Cost Code based on daily average cost of therapy in dollars $ = <20; $$ = 21 - 40; $$$ = 41 - 60; $$$$ = >61; $$$$$ = most expensive
64
Oral Antimicrobials
Antimicrobial
73 71 36 99 93 99 57 37 98 87 59 77 76 90 23 92 80 23 94 45 3 15 0 72 0 98 47 96 85 84
Generic Name
Brand Name
Amoxil amoxicillin amoxicillin + clavulanate Augmentin Polycillin ampicillin azithromycin Zithromax Duricef Omnicef Ceftin Keex Biaxin Cleocin Dynapen E-mycin Levaquin Zyvox Flagyl Macrobid Pen Vee K Rifadin Bactrim Septra
93 100 85
100 99 100 94
When reviewing the patients culture susceptibilities in Cerner, if there is an asterisk (*) beside the antibiotic listed, double clicking on the asterisk (*) beside the antibiotic will provide additional susceptibility and treatment information.
cefadroxil cefdinir cefuroxime axetil cephalexin clarithromycin clindamycin dicloxacillin erythromycin base levooxacin Linezolid metronidazole nitrofurantoin penicillin VK rifampin trimethoprim + sulfamethoxazole
Regimen Daily Cost of Adult Therapy Dose & Interval 250mg-500 mg tid $ 500mg-875mg bid $$ 500mg qid $ 500mgx1; 250mg x 4d $$ 500mg qd $$ 500mg-1gm qd-bid $$ bid $$ 300mg 125mg-500mg bid $$ 250mg-500mg qid $ 250mg-500mg bid $$$ 150mg-300mg qid $ 250mg-1000mg qid $$ 250mg-500mg qid $$$ 750mg qd $$ 600mg bid $$$$ 250mg-500mg qid $ 50mg-100mg qid $$$ 250mg-500mg qid $ 300mg bid $$ 1 double strength bid $
Cost Code based on daily average cost of therapy in dollars $ = <1.00; $$ = 1.01 - 5.25; $$$ = 5.30 - 9.00; $$$$ = >9.01; $$$$$ = most expensive
Gram-Negative Infections
Alternative
Cefadroxil PO or Cephalexin PO or Amoxicillinclavulanate PO Cefazonlin IV Clindamycin IV Doxycycline PO or TMP-SMX PO *Consider IDConsult
Organism
Escherichia coli
Syndrome
UTI(Cystitis)
Preferred
Levooxacin PO or TMP-SMXPO Ceftriaxone IV
Alternative
Nitrofurantoin PO (if CrCI60mL/min) Cefazolin IV or Cefoxitin IVor Levooxacin or Piperacillin / tazobactam IV Levooxacin
Serious infection*
Staphylococcus Skin infection aureus MethicillinSerious infection* resistant (MRSA Coagulase negative staphylococcus Streptococcus (group A) pyogenes
Serious infection*
Klebsiella pneumoniae
UTI(Cystitis)
TMP-SMXPO
Vancomycin IV
*Consider IDConsult
Serious infection*
Cefazolin IV
Pharyngitis
Penicillin V PO
Proteus mirabilis
UTI(Cystitis)
TMP-SMX PO or Levooxacin PO
Serious infection*
Penicillin GIV
UTI(Cystitis)
Ceftriaxone IV
Serious infection*
Penicillin G IV or Ampicillin IV
Serious infection*
Levooxacin
Serious infection*
Pseudomonas aeruginosa
UTI(Cystitis)
Levooxacin PO
*Consider IDConsult
Serious infection*
Piperacillin / tazobactam IV
Ampicillin IV + Gentamicin IV
*Consider IDConsult
MeropenemIV
*serious infection = e.g. bacteremia, pneumonia, meningitis. Consider ID consult for serious infection.
Anaerobic Infections
Organism
Clostridium difcile
Syndrome
Mild/Moderate Serious infection*
Preferred
Metronidazole PO Vancomycin PO Metronidazole IV
Alternative
Resources: The Medical Letter Therapeutic Guidelines; 2007. Sanford Guide to Antimicrobial Therapy; 2010. John Hopkins ABXGuide: http://hopkins-abxguide.org/
Bacteroides fragilis
This therapy card should be used as an aid in making decisions and is NOT meant to be a comprehensive reference. Susceptibility tests should be used along with clinical judgement for choosing optimal antimicrobial therapy.